A population-based recurrence risk management study of patients with pT1 node-negative HER2+ breast cancer: a National Clinical Database study-Reference-Cited by-同舟云学术

A population-based recurrence risk management study of patients with pT1 node-negative HER2+ breast cancer: a National Clinical Database study

Published:2019-08-26 Issue:3 Volume:178 Page:647-656
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Treat

Author:

Kubo Makoto^ORCID,Kawai Masaaki,Kumamaru Hiraku,Miyata Hiroaki,Tamura Kenji,Yoshida Masayuki,Ogo Etsuyo,Nagahashi Masayuki,Asaga Sota,Kojima Yasuyuki,Kadoya Takayuki,Aogi Kenjiro,Niikura Naoki,Miyashita Minoru,Iijima Kotaro,Hayashi Naoki,Yamamoto Yutaka,Imoto Shigeru,Jinno Hiromitsu

Funder

Japanese Breast Cancer Society

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s10549-019-05413-7.pdf

Reference33 articles.

1. Japanese Breast Cancer Society: http://jbcs.gr.jp/member/en/ . Accessed 21 Feb 2019

2. Kennedy T, Stewart AK, Bilimoria KY et al (2007) Treatment trends and factors associated with survival in T1aN0 and T1bN0 breast cancer patients. Ann Surg Oncol 14:2918–2927

3. Berry DA, Cronin KA, Plevritis SK et al (2005) Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med 353:1784–1792